Fibroids and urinary symptoms study (FUSS)
. The Symptom Severity subscale of the UFS-QOL is composed of 8 items, whereas the PFDI-20 contains 20 items with 3 subscales: the Pelvic Organ Prolapse Distress Inventory (POPDI-6), Colorectal-Anal Distress Inventory (CRADI-8), and the Urinary Distress Inventory (UDI-6). Scores on both the Symptom Severity subscale of the UFS-QOL and the PFDI-20 range from 0 to 100, with higher scores indicating greater symptom severity or bother. RESULTS: One hundred ninety-five women with mean age of 41 AE 6 years and BMI of 29 AE 7 kg/m 2 were included in this analysis. Fiftyeight percent identified as black, 32% as white, and 6% as Asian. Median parity was 0 (0-4) with 38% of women having had at least one vaginal delivery. Mean age at fibroid diagnosis was 34 AE 7 years. Women commonly attributed heavy vaginal bleeding (81%), pelvic pain (68%), increased abdominal size (66%), length of menses (56%), dyspareunia (37%), and urinary incontinence (31%) to their fibroids. The mean UFS-QOL Symptom Severity subscale score was 48.7 AE 25.4 for the cohort, with 81% of participants reporting being at least "somewhat bothered" by heavy bleeding during menses, 79% by passing clots, 66% by feeling fatigued, 63% by tightness or pressure in pelvic area, 60% by frequent daytime urination, and 47% by frequent night time urination. Mean PFDI-20 score was 45.5 AE 31.9 for the cohort with mean subscale scores of 17.2 AE 12.2, 9.3 AE 10.7, and 19.0 AE 15.8 for the POPDI-6, CRADI-8, and UDI-6, respectively. Women most commonly reported being at least "somewhat bothered" by pressure in the abdomen (71%), heaviness or dullness in the pelvis (60%), frequent urination (56%), pelvic pain or discomfort (48%), sensation of incomplete bladder emptying (43%), and incomplete emptying at the end of a bowel movement (42%). Fewer women reported bother from stress urinary incontinence (36%), urgency urinary incontinence (35%), and difficulty with bladder emptying (21%). Other pelvic floor symptoms such as vaginal bulge (15%), needing to push on the vagina or around the rectum to complete a bowel movement (12%), and needing to push in the vagina to initiate or complete urination (7%) were uncommon. CONCLUSION: Women presenting for evaluation and treatment of fibroids report high rates of pelvic floor symptom bother, particularly related to urinary frequency and pelvic pressure. Given the observed frequency of pelvic floor symptoms, future studies should assess interventions for pelvic floor dysfunction in this patient population.
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